Login / Signup

Efficacy and Safety of Pea Protein and Xyloglucan Versus Simethicone in Functional Abdominal Bloating and Distension.

Diana Corina PetrisorZlatka EtropolskaKiril ElenskiEmiliya DimitrovaJavier Santos
Published in: Digestive diseases and sciences (2023)
This study supports the evidence that FABD patients may benefit from a XG + PP-based treatment that acts on etiology and not just the symptoms.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • peritoneal dialysis
  • patient reported outcomes
  • depressive symptoms
  • amino acid
  • small molecule